封面
市場調查報告書
商品編碼
1625446

動物抗生素市場、佔有率、規模、趨勢、行業分析報告(按動物類型、藥物類別、劑型和地區)- 市場預測,2025-2034 年

Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type, Drug Class, Dosage Form, and Region - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 122 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究,全球獸用抗生素市場規模預計到 2034 年將達到 64.3 億美元。該報告提供了有關當前市場動態的詳細見解,並對未來市場的成長進行了分析。

獸用抗生素是專門用於治療動物細菌感染的藥物。抗生素透過消除或抑制有害細菌的生長來幫助動物恢復。

由於各大公司的措施和新產品的推出,獸用抗生素和離子載體越來越受到關注。牲畜疾病不斷增加,各大公司都在積極推出新型抗生素以滿足需求。

由於人們對人畜共患疾病認識的不斷提高、動物疾病發病率的不斷上升以及對動物源性食品的需求不斷增加,預計預測期內獸用抗生素市場將出現增長。此外,嚴格的疾病預防法規、不斷增長的動物數量、不斷增加的寵物擁有量以及不斷擴大的寵物健康保險市場正在推動市場成長。

伴侶動物擁有量的增加推動了對獸醫服務和產品(包括抗生素)的需求。隨著越來越多的人將寵物帶入家中,全球對這些動物的醫療保健、預防性護理和治療的需求持續增加。

根據2024年7月中央疾病管制報告,預防在動物和人之間傳播的人畜共通傳染病需要採取 "同一個健康" 方法進行有效控制。值得注意的是,人類60%的傳染病源自於動物,包括愛滋病毒、狂犬病等病原體。此外,大多數新興傳染病和80%的生物恐怖主義相關疾病(如炭疽病)都是人畜共通的。動物中此類疾病發生率的不斷上升推動了獸用抗生素市場的擴張。

動物抗生素報告重點

按動物類型劃分,2024 年牛類佔據獸用抗生素市場的主導地位,這是由於牛肉和乳製品消費量的增加需要加強動物健康管理。

依藥物類別劃分,四環素類藥物因其治療用途在 2024 年佔據市場主導地位。這些抗生素被廣泛用作食用動物的第一線治療,並經常用於治療狗、貓和馬等伴侶動物。四環素類藥物,例如阿克羅黴素、蘇米星、美迪環素和四環素,用於獸醫學,特別是用於對抗動物的細菌感染和發炎性皮膚病。

由於在寵物護理(包括食品、醫療保健和美容)方面的支出很高,預計未來幾年歐洲獸醫市場將會成長。此外,智慧寵物設備等技術進步也促進了市場的成長。消費者偏好的變化,尤其是對飲食和素食寵物食品的需求不斷增加,也支持了市場的成長。

全球市場的一些主要參與者包括 Merck &Co., Inc.、Ceva Sante Animale、Vetoquinol、Zoetis Services LLC、Boehringer Ingelheim International GmbH、Dechra Pharmaceuticals PLC、Elanco Animal Health Incorporated、Virbac S.A.、Calier、Bimeda Inc. 、Prodivet Pharmaceuticals SA/NV 和Norbrook Laboratories。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章 研究方法

第 4 章。
  • 市場概況
  • 動物抗生素市場動態
    • 推動因素和機遇
      • 對動物性食品的需求不斷增加
      • 牲畜疾病發生率增加
    • 阻礙因素和課題
      • 強而有力的監管框架
  • PESTEL 分析
  • 動物抗生素市場的趨勢
  • 價值鏈分析
  • COVID-19 影響分析

5. 全球動物抗生素市場(以動物類型)

  • 主要發現
  • 簡介
  • 綿羊和山羊
  • 家禽
  • 其他

6. 全球動物抗生素市場(依藥物類別)

  • 主要發現
  • 簡介
  • 四環素
  • 青黴素
  • 磺胺類藥物
  • 大環內酯類
  • 甲氧芐啶 林可醯胺類
  • 多粘菌素
  • 氨基糖甘類
  • 氟奎諾酮類藥物
  • 截短側耳素
  • 其他

7. 全球動物抗生素市場(以劑型劃分)

  • 主要發現
  • 簡介
  • 口服粉
  • 口服溶液
  • 注入
  • 其他

8. 全球動物抗生素市場(按地區)

  • 主要發現
  • 簡介
    • 動物抗生素市場評估:地區,2020-2034 年
  • 北美洲
    • 2020 年至 2034 年,北美各動物類型
    • 北美:依藥物類別,2020 年至 2034 年
    • 2020 年至 2034 年,北美以劑型劃分
    • 美國
    • 加拿大
  • 歐洲
      2020 年至 2034 年歐洲各動物類型 歐洲:依藥物類別劃分,2020 年至 2034 年 歐洲:依劑型劃分,2020-2034 年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
    亞太地區
      亞太地區,依動物類型,2020-2034 年 亞太地區,依藥物類別,2020 年至 2034 年 2020 年至 2034 年亞太地區劑型分類
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
      中東和非洲:依動物類型,2020-2034 年 中東和非洲:毒品類別,2020 年至 2034 年 中東和非洲:按劑型劃分,2020 年至 2034 年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲,依動物類型,2020 年至 2034 年 2020 年至 2034 年拉丁美洲各毒品類別
    • 2020 年至 2034 年拉丁美洲按劑型劃分的情況
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第 9 章 競爭格局

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協定/揭露

第十章 公司簡介

  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Calier
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Norbrook Laboratories
  • Prodivet Pharmaceuticals SA/NV
  • Vetoquinol
  • Virbac S.A.
  • Zoetis Services LLC
Product Code: PM5317

The global veterinary antibiotics market size is expected to reach USD 6.43 billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type (Pigs, Cattle, Sheep & Goats, Poultry, and Others), Drug Class, Dosage Form, and Region (North America, Europe, Asia Pacific, and Rest of World) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary antibiotics are medications specifically designed for treating bacterial infections in animals. The antibiotics eliminate harmful bacteria or inhibit their growth, thus assisting in the animal's recovery.

There is a growing emphasis on animal-specific antibiotics and ionophores, driven by initiatives from major companies and the introduction of new products. The incidence of livestock diseases is on the rise, leading key players to actively release new antibiotics to meet demand, especially as older antibiotics have been linked to resistance.

The veterinary antibiotics market is expected to grow during the forecast period due to increased awareness of zoonotic diseases, rising animal disease outbreaks, and higher demand for animal-derived food products. Additionally, stringent disease prevention regulations, a growing animal population, increased pet adoption, and the expanding pet health insurance market are driving the market growth.

The increasing adoption of companion animals is propelling the demand for veterinary services and products, including antibiotics. As more people bring pets into their homes, the need for healthcare, preventive measures, and treatments for these animals continues to increase globally.

According to the central disease control report in July 2024, prevention of Zoonotic diseases, which are transmissible between animals and humans, requires a One Health approach for effective management. Notably, 60% of human infectious diseases originate from animals, including pathogens such as HIV and rabies. Additionally, most emerging infectious diseases and 80% of bioterrorism-related diseases, such as anthrax, are zoonotic. The increasing incidence of such diseases among animals boosts the veterinary antibiotics market expansion.

Veterinary Antibiotics Report Highlights

By animal type, the cattle segment dominated the veterinary antibiotics market in 2024 due to the rising consumption of beef and dairy products that necessitate enhanced animal health management.

Based on drug class, in 2024, the tetracyclines segment dominated the market due to their therapeutic applications. These antibiotics are widely used as first-line treatments for food-producing animals and are also frequently administered to companion animals, including dogs, cats, and horses. Tetracycline-based medications such as Achromycin, Sumycin, Medicycline, and Tetracyn are specifically used in veterinary medicine to address bacterial infections and inflammatory skin conditions in animals.

The European veterinary market is expected to grow in the coming years due to the high expenditure on pet care, encompassing food, healthcare, and grooming. Furthermore, technological advancements such as smart pet devices are contributing to the market growth. Shifting consumer preferences, particularly the increasing demand for dietary and vegan pet food, also support the market growth.

A few global key market players are Merck & Co., Inc.; Ceva Sante Animale; Vetoquinol; Zoetis Services LLC; Boehringer Ingelheim International GmbH; Dechra Pharmaceuticals PLC; Elanco Animal Health Incorporated; Virbac S.A.; Calier, Bimeda, Inc.; Prodivet Pharmaceuticals SA/NV; and Norbrook Laboratories.

Polaris Market Research has segmented the veterinary antibiotics market report on the basis of animal type, drug class, dosage form, and region:

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

  • Pigs
  • Cattle
  • Sheep & Goats
  • Poultry
  • Others

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Trimethoprim
  • Lincosamides
  • Polymyxins
  • Aminoglycosides
  • Fluoroquinolones
  • Pleuromutilins
  • Other

By Dosage Form Outlook (Revenue, USD Billion, 2020-2034)

  • Oral Powders
  • Oral Solutions
  • Injections
  • Other

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Veterinary Antibiotics Market Insights

  • 4.1. Veterinary Antibiotics Market - Market Snapshot
  • 4.2. Veterinary Antibiotics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Animal-Derived Food Products
      • 4.2.1.2. Increasing Incidence of Livestock Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Strict regulatory framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Antibiotics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Antibiotics Market, by Animal Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
  • 5.3. Pigs
    • 5.3.1. Global Veterinary Antibiotics Market, by Pigs, by Region, 2020-2034 (USD Billion)
  • 5.4. Cattle
    • 5.4.1. Global Veterinary Antibiotics Market, by Cattle, by Region, 2020-2034 (USD Billion)
  • 5.5. Sheep & Goats
    • 5.5.1. Global Veterinary Antibiotics Market, by Sheep & Goats, by Region, 2020-2034 (USD Billion)
  • 5.6. Poultry
    • 5.6.1. Global Veterinary Antibiotics Market, by Poultry, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Antibiotics Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
  • 6.3. Tetracyclines
    • 6.3.1. Global Veterinary Antibiotics Market, by Tetracyclines, by Region, 2020-2034 (USD Billion)
  • 6.4. Penicillins
    • 6.4.1. Global Veterinary Antibiotics Market, by Penicillins, by Region, 2020-2034 (USD Billion)
  • 6.5. Sulfonamides
    • 6.5.1. Global Veterinary Antibiotics Market, by Sulfonamides, by Region, 2020-2034 (USD Billion)
  • 6.6. Macrolides
    • 6.6.1. Global Veterinary Antibiotics Market, by Macrolides, by Region, 2020-2034 (USD Billion)
  • 6.7. Trimethoprim
    • 6.7.1. Global Veterinary Antibiotics Market, by Trimethoprim, by Region, 2020-2034 (USD Billion)
  • 6.8. Lincosamides
    • 6.8.1. Global Veterinary Antibiotics Market, by Lincosamides, by Region, 2020-2034 (USD Billion)
  • 6.9. Polymyxins
    • 6.9.1. Global Veterinary Antibiotics Market, by Polymyxins, by Region, 2020-2034 (USD Billion)
  • 6.10. Aminoglycosides
    • 6.10.1. Global Veterinary Antibiotics Market, by Aminoglycosides, by Region, 2020-2034 (USD Billion)
  • 6.11. Fluoroquinolones
    • 6.11.1. Global Veterinary Antibiotics Market, by Fluoroquinolones, by Region, 2020-2034 (USD Billion)
  • 6.12. Pleuromutilins
    • 6.12.1. Global Veterinary Antibiotics Market, by Pleuromutilins, by Region, 2020-2034 (USD Billion)
  • 6.13. Others
    • 6.13.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Antibiotics Market, by Dosage Form

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 7.3. Oral Powders
    • 7.3.1. Global Veterinary Antibiotics Market, by Oral Powders, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral Solutions
    • 7.4.1. Global Veterinary Antibiotics Market, by Oral Solutions, by Region, 2020-2034 (USD Billion)
  • 7.5. Injections
    • 7.5.1. Global Veterinary Antibiotics Market, by Injections, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Antibiotics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Veterinary Antibiotics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Veterinary Antibiotics Market - North America
    • 8.3.1. North America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.3.3. North America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.4. Veterinary Antibiotics Market - U.S.
      • 8.3.4.1. U.S.: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.5. Veterinary Antibiotics Market - Canada
      • 8.3.5.1. Canada: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.4. Veterinary Antibiotics Market - Europe
    • 8.4.1. Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.4. Veterinary Antibiotics Market - UK
      • 8.4.4.1. UK: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.5. Veterinary Antibiotics Market - France
      • 8.4.5.1. France: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.6. Veterinary Antibiotics Market - Germany
      • 8.4.6.1. Germany: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.7. Veterinary Antibiotics Market - Italy
      • 8.4.7.1. Italy: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.8. Veterinary Antibiotics Market - Spain
      • 8.4.8.1. Spain: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.9. Veterinary Antibiotics Market - Netherlands
      • 8.4.9.1. Netherlands: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.10. Veterinary Antibiotics Market - Russia
      • 8.4.10.1. Russia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.11. Veterinary Antibiotics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.5. Veterinary Antibiotics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.4. Veterinary Antibiotics Market - China
      • 8.5.4.1. China: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.5. Veterinary Antibiotics Market - India
      • 8.5.5.1. India: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.6. Veterinary Antibiotics Market - Malaysia
      • 8.5.6.1. Malaysia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.7. Veterinary Antibiotics Market - Japan
      • 8.5.7.1. Japan: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.8. Veterinary Antibiotics Market - Indonesia
      • 8.5.8.1. Indonesia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.9. Veterinary Antibiotics Market - South Korea
      • 8.5.9.1. South Korea: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.10. Veterinary Antibiotics Market - Australia
      • 8.5.10.1. Australia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.11. Veterinary Antibiotics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.6. Veterinary Antibiotics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.4. Veterinary Antibiotics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.5. Veterinary Antibiotics Market - UAE
      • 8.6.5.1. UAE: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.6. Veterinary Antibiotics Market - Israel
      • 8.6.6.1. Israel: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.7. Veterinary Antibiotics Market - South Africa
      • 8.6.7.1. South Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.8. Veterinary Antibiotics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.7. Veterinary Antibiotics Market - Latin America
    • 8.7.1. Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.4. Veterinary Antibiotics Market - Mexico
      • 8.7.4.1. Mexico: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.5. Veterinary Antibiotics Market - Brazil
      • 8.7.5.1. Brazil: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.6. Veterinary Antibiotics Market - Argentina
      • 8.7.6.1. Argentina: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.7. Veterinary Antibiotics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bimeda, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Boehringer Ingelheim International GmbH
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Calier
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ceva Sante Animale
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dechra Pharmaceuticals PLC
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Elanco Animal Health Incorporated
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck & Co., Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Norbrook Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Prodivet Pharmaceuticals SA/NV
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Vetoquinol
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Virbac S.A.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Zoetis Services LLC
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

Table 1 Global Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 2 Global Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 3 Global Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 4 North America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 5 North America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 6 North America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 7 U.S.: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 8 U.S.: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 9 U.S.: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 10 Canada: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 11 Canada: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 12 Canada: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 13 Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 14 Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 15 Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 16 UK: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 17 UK: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 18 UK: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 19 France: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 20 France: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 21 France: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 22 Germany: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 23 Germany: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 24 Germany: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 25 Italy: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 26 Italy: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 27 Italy: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 28 Spain: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 29 Spain: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 30 Spain: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 31 Netherlands: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 32 Netherlands: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 33 Netherlands: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 34 Russia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 35 Russia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 36 Russia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 37 Rest of Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 38 Rest of Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 39 Rest of Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 40 Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 41 Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 42 Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 43 China: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 44 China: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 45 China: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 46 India: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 47 India: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 48 India: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 49 Malaysia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 50 Malaysia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 51 Malaysia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 52 Japan: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 53 Japan: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 54 Japan: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 55 Indonesia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 56 Indonesia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 57 Indonesia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 58 South Korea: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 59 South Korea: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 60 South Korea: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 61 Australia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 62 Australia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 63 Australia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 64 Rest of Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 65 Rest of Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 66 Rest of Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 67 Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 68 Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 69 Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 70 Saudi Arabia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 71 Saudi Arabia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 72 Saudi Arabia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 73 UAE: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 74 UAE: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 75 UAE: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 76 Israel: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 77 Israel: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 78 Israel: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 79 South Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 80 South Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 81 South Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 82 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 83 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 84 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 85 Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 86 Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 87 Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 88 Mexico: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 89 Mexico: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 90 Mexico: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 91 Brazil: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 92 Brazil: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 93 Brazil: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 94 Argentina: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 95 Argentina: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 96 Argentina: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 97 Rest of Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 98 Rest of Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 99 Rest of Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Veterinary Antibiotics Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Animal Type

Figure 7. Global Veterinary Antibiotics Market, by Animal Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Drug Class

Figure 9. Global Veterinary Antibiotics Market, by Drug Class, 2024 & 2034 (USD Billion)

Figure 10. Market by Dosage Form

Figure 11. Global Veterinary Antibiotics Market, by Dosage Form, 2024 & 2034 (USD Billion)